ILMN - イルミナ (Illumina Inc.)

ILMNのニュース

   Has the era of liquid biopsies finally arrived? Illumina thinks so (NASDAQ:ILMN)  2020/09/26 06:00:00 Seeking Alpha
Illumina's (NASDAQ:ILMN) $8B takeout of liquid biopsy developer GRAIL, which it formed in 2016 with funding assistance from the likes of Bill Gates and Jef
   Johnson & Johnson, Nike, Illumina: Stocks That Defined the Week  2020/09/25 23:17:00 The Wall Street Journal
Here are seven major companies whose stocks moved on the week’s news.
   Illumina and Grail CEOs defend their deal to investors  2020/09/25 16:52:40 STAT News
The CEOs of the two companies told STAT it would take time for investors to understand the advantages of combining the two firms.
   Illumina Stock Drops Lower After Slew of Bear Notes  2020/09/22 16:30:15 Schaeffers Investment Research
ILMN earned six price target cuts after announcing plans to acquire Grail, a cancer diagnostics firm
   Top Analyst Upgrades and Downgrades: Alibaba, Amazon, Apple, Carvana, Illumina, NextEra, Nikola, Shake Shack, Teladoc, WPX Energy and More  2020/09/22 12:59:09 24/7 Wall street
   Illumina Buys Out Big Investors With $8B Acquisition Of Grail  2020/09/21 20:36:58 Crunchbase News
Gene sequencing firm Illumina plans to buy cancer screening startup Grail in a cash-and-stock deal worth $8 billion.
   Nikola, Illumina fall; Cubic, Rent-A-Center rise  2020/09/21 20:29:00 ABC News
Stocks that moved heavily or traded substantially Monday: Nikola, Illumina fall; Cubic, Rent-A-Center rise
   What This Acquisition Adds to Illumina  2020/09/21 15:44:17 24/7 Wall street
   Illumina Confirms $8B Acquisition Of Cancer-Detection Firm Grail  2020/09/21 13:18:24 Smarter Analyst
Gene sequencing firm Illumina announced today the acquisition of Grail, a company focused on multi-cancer early detection, for $8 billion. Last week, a … The post Illumina Confirms $8B Acquisition Of Cancer-Detection Firm Grail appeared first on Smarter Analyst .
   Inside Big Pharma's work with celebs  2020/09/21 13:02:51 Business Insider
Summary List Placement Hello, Welcome back to the workweek. I, for one, have never been less excited to receive a flurry of texts from friends than I was Friday night, when we learned that Supreme Court Justice Ruth Bader Ginsburg had died at 87 of complications related to pancreatic cancer . I'll be spending a lot of this week thinking about her legacy in healthcare and what might come next as the Supreme Court prepares to hear arguments related to the Affordable Care Act. In healthcare news, we're already off to a busy start with the news that Illumina is acquiring its once-spinout Grail, a company focused on early cancer detection testing. Over the years, Grail has racked up more than $1.9 billion in funding from the likes of Jeff Bezos and Bill Gates and pharma giants like Merck. Prior to Illumina swooping in, Grail had recently filed to go public. The CDC reversed course yet again, removing widely condemned language about not testing asymptomatic people for the coronavirus The CDC is once again recommending that people get tested for the coronavirus if they've been in close contact with an infected person — even if they're not showing symptoms.
   Grail files to launch IPO  2020/09/10 15:28:07 SmartBrief
Biotechnology firm Grail has submitted a filing for its planned initial public offering on Nasdaq. The Illumina spinout plans to develop a blood test that can detect early cancer and is backed by Amazon CEO Jeff Bezos and Johnson & Johnson.
   Top Analyst Upgrades and Downgrades: Aramark, Coupa, DraftKings, Duke, eGain, FedEx, Illumina, Lululemon, Nikola, Slack, Vroom and More – Page 2 – 24/7 Wall St.  2020/09/09 12:57:29 24/7 Wall street
Wednesday's top analyst upgrades and downgrades included Aramark, Coupa Software, DraftKings, Duke Energy, eGain, FedEx, Illumina, Lululemon Athletica, Nikola, Slack Technologies and Vroom.
   Illumina collabore avec 54gene à la création d’une installation de génomique de classe mondiale au Nigéria  2020/09/04 01:12:00 Business Wire
CAMBRIDGE, Angleterre--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ : ILMN) a annoncé aujourd’hui une collaboration avec 54gene, une société de technologie de la santé dont la mission consiste à faire progresser les capacités de la médecine de précision en Afrique grâce à la recherche, des diagnostics moléculaires avancés et des programmes cliniques. Le partenariat permettra la création de nouvelles installations de génétique à Lagos, au Nigéria, équipées d’une série de plateformes technologiques de
   Resumen: Illumina colabora con 54gene en la creación de un centro de genómica de clase mundial en Nigeria  2020/09/03 22:42:00 Business Wire
CAMBRIDGE, Inglaterra--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) ha anunciado hoy una colaboración con 54gene, una empresa de tecnología sanitaria cuya misión es hacer avanzar las capacidades de la medicina de precisión en África a través de la investigación, los diagnósticos moleculares avanzados y los programas clínicos. La asociación ayudará a la creación de una nueva instalación genética en Lagos (Nigeria), equipada con un conjunto de plataformas tecnológicas de secuenciación y de micr
   Illumina Collaborates With 54gene in the Creation of a World-Class Genomics Facility in Nigeria  2020/09/03 08:00:00 Business Wire
CAMBRIDGE, England--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration with 54gene, a health technology company whose mission is to advance precision medicine capabilities in Africa through research, advanced molecular diagnostics and clinical programs. The partnership will support the establishment of a new genetics facility in Lagos, Nigeria, equipped with a suite of Illumina's cutting-edge sequencing and high-density microarray technology platforms, which will gen

calendar